A minimalist cancer cell membrane-shielded biomimetic nanoparticle for nasopharyngeal carcinoma active-targeting...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Nasopharyngeal carcinoma (NPC) presents a significant challenge due to its aggressive nature, late diagnosis, and limited treatment options.
• Developing targeted drug delivery systems is crucial for improving NPC therapeutic efficacy.
• Biomimetic nanoparticles offer a promising approach for cancer therapy.

Purpose of the Study:

• To design and evaluate a minimalist cancer cell membrane (CCM)-shielded nanoparticle for active-targeting therapy of nasopharyngeal carcinoma (NPC).
• To investigate the drug-loading capacity, stability, cellular uptake, and in vivo therapeutic efficacy of the novel nanoplatform.

Main Methods:

• Doxorubicin (DOX) was loaded into polyamidoamine (PAMAM) dendrimers to create PAMAM/DOX (PD) nanoparticles.
• The PD nanoparticles were shielded with human CNE-2 NPC cancer cell membranes (CCM) to form PDC nanoparticles.
• Characterization of physical properties, DOX loading, stability, cellular uptake studies (in vitro), and tumor targeting and suppression studies (in vivo) were performed.

Main Results:

• The resulting PAMAM/DOX@CCM (PDC) nanoparticles exhibited favorable physical properties, high drug loading, and excellent stability.
• PDC nanoparticles demonstrated enhanced cellular uptake in CNE-2 cells via homologous targeting and adhesion.
• In vivo studies showed prolonged circulation, significant tumor targeting, and effective suppression of CNE-2 tumor progression.

Conclusions:

• The CCM-shielded biomimetic nanoparticle (PDC) represents a minimalist nanoplatform for precise NPC therapy.
• This cancer cell membrane-shielded biomimetic drug delivery system (DDS) holds substantial potential for broad applications in active-targeting cancer therapy.